Press/Media
- 1 - 50 out of 283 results
Search results
-
Diabetes drugs found to lower risk of dementia in large analysis
2/09/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: Reaction to MHRA decision and NICE draft guidance on lecanemab //...
30/08/24
1 Media contribution
Press/Media: Research
-
A diabetes drug might lower dementia risk, new study suggests
Tara Spires-Jones & William Whiteley
30/08/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to observational study claiming certain diabetes drugs might prevent...
Tara Spires-Jones & William Whiteley
29/08/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to MHRA and NICE news on lecanemab for Alzheimer's...
22/08/24
1 Media contribution
Press/Media: Research
-
UK health regulator rejects lecanemab as treatment for Alzheimer's
22/08/24
1 Media contribution
Press/Media: Research
-
Blood tests could soon predict your risk of Alzheimer's
7/08/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to perspective article considering challenges for the new Alzheimer's...
Tara Spires-Jones & Thomas Russ
6/08/24
1 Media contribution
Press/Media: Research
-
Many dementia cases could be prevented, but far from all: study
5/08/24
1 Media contribution
Press/Media: Research
-
As vision problems and cholesterol can increase the risk of dementia
3/08/24
1 Media contribution
Press/Media: Research
-
Many dementia cases could be prevented, but far from all: study
1/08/24
1 Media contribution
Press/Media: Research
-
Many dementia cases could be prevented, but far from all: study
1/08/24
1 Media contribution
Press/Media: Research
-
Expert: Tau Oligomers Are a Culprit in the Spread of Alzheimer Disease Pathology
1/08/24
1 Media contribution
Press/Media: Research
-
Lifestyle changes could prevent nearly half of dementia cases: study
1/08/24
1 Media contribution
Press/Media: Research
-
As vision problems and cholesterol can increase the risk of dementia
1/08/24
1 Media contribution
Press/Media: Research
-
-
New Alzheimer's Drug Rejected by European Medicines Agency Committee
31/07/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to 2024 Lancet Commission report on dementia prevention, intervention,...
31/07/24
1 Media contribution
Press/Media: Research
-
The herpes zoster vaccine prevents dementia
Richard Lathe
31/07/24
1 Media contribution
Press/Media: Research
-
Many dementia cases could be prevented, but far from all: study
31/07/24
1 Media contribution
Press/Media: Research
-
-
Why the European Union has refused to approve lecanemab against Alzheimer's.
30/07/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to conference abstract on phase 2b trial of liraglutide...
30/07/24
1 Media contribution
Press/Media: Research
-
The European medicines Agency refuses to introduce a drug that slows the progression of Alzheimer's disease
28/07/24
1 Media contribution
Press/Media: Research
-
European medicines reject a drug that slows the development of Alzheimer's.
28/07/24
1 Media contribution
Press/Media: Research
-
"Unsafe".. European Medicines Agency rejects the launch of a drug that slows the development of Alzheimer's
27/07/24
1 Media contribution
Press/Media: Research
-
The European medicines Agency refuses to introduce a drug that slows the progression of Alzheimer's disease
27/07/24
1 Media contribution
Press/Media: Research
-
Europe rejects approval for Alzheimer's from lecanemab, a drug that slows down cognitive decline
26/07/24
1 Media contribution
Press/Media: Research
-
European Medicines Agency blocks drug against Alzheimer's authorised in the USA
26/07/24
1 Media contribution
Press/Media: Research
-
Europe rejects approval for Alzheimer's from lecanemab, a drug that slows down cognitive decline
26/07/24
1 Media contribution
Press/Media: Research
-
Leqembi a treatment against Alzheimer's disease suspended in Europe
26/07/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to EMA decision on lecanemab for Alzheimer's disease
26/07/24
1 Media contribution
Press/Media: Research
-
Alzheimer's disease: The European Medicines Agency blocks the authorisation of a new treatment
26/07/24
1 Media contribution
Press/Media: Research
-
The European Medicines Agency is blocking a highly anticipated treatment for Alzheimer's.
26/07/24
1 Media contribution
Press/Media: Research
-
The EU advises not to approve lecanemab, a controversial drug for Alzheimer's.
26/07/24
1 Media contribution
Press/Media: Research
-
Alzheimer' s: The European Medicines Agency blocks a long-awaited treatment
26/07/24
1 Media contribution
Press/Media: Research
-
Evidence mounts that shingles vaccines protect against dementia
Richard Lathe
25/07/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to study suggesting new shingles vaccine associated with lower...
25/07/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to study looking at concussion- related biomarkers in retired...
17/07/24
1 Media contribution
Press/Media: Research
-
-
“A nose job.” A new drug for Alzheimer's disease with promising results
12/07/24
1 Media contribution
Press/Media: Research
-
Nasal spray found to clear tau proteins from Alzheimer's mouse model brains
11/07/24
1 Media contribution
Press/Media: Research
-
Dementia test can predict illness nine years before symptoms
6/06/24
11 Media contributions
Press/Media: Research
-
-
Alzheimer's disease: A study identified a new genetic form present in millions of people
6/05/24 → 7/05/24
11 Media contributions
Press/Media: Research
-
What is dementia? Types, symptoms, causes and treatment
5/05/24
1 Media contribution
Press/Media: Research
-
What is Alzheimer's disease? Signs, diagnosis and treatment
4/04/24
1 Media contribution
Press/Media: Research
-
AI is a viable alternative to high throughput screening: a 318-target study
2/04/24
1 Media contribution
Press/Media: Research
-
MIL-OSI United Kingdom: expert reaction to study looking at a mouse model of a stem cell transplant that reports transmission of a rare familial form of Alzheimer's disease
28/03/24
1 Media contribution
Press/Media: Research